Appearing far from the frail image of Pauline Newman painted by recent public discourse, the 95-year-old judge on the U.S. Court of Appeals for the Federal Circuit took the stage at a recent vaccine law conference in Washington D.C. As reported by Reuters, Newman urged more scrutiny into how patent law could affect the development of vaccines and other pivotal technologies.
Newman, the longest-serving member of the patent-focused U.S. Court of Appeals for the Federal Circuit, emphasized the importance of understanding not just how present law applies but also its effectiveness. “We must understand not just how the present law applies, but also to understand if it’s anything less than optimum, it’s in our hands,” she said during the panel discussion.
Newman has been rock steady in her stance on patent law and its potential implications on innovation. Her dissenting opinions have often voiced concern about the unpredictable and diverse nature of contemporary patent eligibility and its potentially adverse impact on the incentive for innovation across all fields of technology.
Some may remember a previous instance where Newman demonstrated a lively intellectual capability was an extended interview with The Washington Post, where she was remarked upon for her organization. This paints a picture blatantly contradicting the portrayal of her as unable to serve due to cognitive decline.
The focus on Newman’s fitness seems undue when the judiciary sees bigger issues, such as ethical misconduct involving a Supreme Court justice or the dubious practice of some wanting to seek references from religious texts instead of dictionaries for interpretative guidance.
Embattled US Appeals Judge Takes Stage At Vaccine Law Conference [Reuters]
What seemed like an attack on a judge’s ability to fulfill her role and a focus on Newman’s dissents than her colleagues’ speculations about her health, has become an opportunity to appreciate a seasoned mind’s commitment towards innovation in law and policy.